KPTI
Karyopharm Therapeutics Inc
Price:  
4.65 
USD
Volume:  
177,680.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI Relative Valuation

-2247.6%
Upside

As of 2025-07-09, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (99.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.65 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -2247.6%.

The range of the Relative Valuation is (95.23) - (114.77) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 9.1x - 15.9x 11.1x
Forward P/E multiples 13.2x - 21.0x 16.5x
Fair Price (95.23) - (114.77) (99.86)
Upside -2148.0% - -2568.1% -2247.6%
4.65 USD
Stock Price
(99.86) USD
Fair Price

KPTI Relative Valuation - Historical P/E Data

Date P/E
2025-07-08 -0.64
2025-07-07 -0.58
2025-07-03 -0.61
2025-07-02 -0.64
2025-07-01 -0.60
2025-06-30 -0.60
2025-06-27 -0.61
2025-06-26 -0.62
2025-06-25 -0.62
2025-06-24 -0.64
2025-06-23 -0.60
2025-06-20 -0.61
2025-06-18 -0.61
2025-06-17 -0.60
2025-06-16 -0.63
2025-06-13 -0.61
2025-06-12 -0.60
2025-06-11 -0.61
2025-06-10 -0.61
2025-06-09 -0.58
2025-06-06 -0.62
2025-06-05 -0.59
2025-06-04 -0.60
2025-06-03 -0.59
2025-06-02 -0.57
2025-05-30 -0.58
2025-05-29 -0.63
2025-05-28 -0.62
2025-05-27 -0.63
2025-05-23 -0.63
2025-05-22 -0.64
2025-05-21 -0.65
2025-05-20 -0.71
2025-05-19 -0.71
2025-05-16 -0.74
2025-05-15 -0.75
2025-05-14 -0.67
2025-05-13 -0.68
2025-05-12 -0.85
2025-05-09 -0.83
2025-05-08 -0.85
2025-05-07 -0.84
2025-05-06 -0.87
2025-05-05 -0.98
2025-05-02 -1.02
2025-05-01 -0.93
2025-04-30 -0.93
2025-04-29 -0.88
2025-04-28 -0.84
2025-04-25 -0.78